Respiratory syncytial virus mRNA vaccine(Amy Biovaccine)

呼吸道合胞病毒mRNA疫苗（艾美疫苗）

Report date: 2025/05/28 15:20:48

Base Information

Drug NameRespiratory syncytial virus mRNA vaccine(Amy Biovaccine)

Drug Alias Name呼吸道合胞病毒（RSV）mRNA疫苗mRNA 呼吸道合胞病毒RSV疫苗

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesAim Vaccine Co Ltd 艾美创新者生物医药研究（上海）有限公司 Aimei Explorer Life Science R&D Co Ltd

China Registration ClassN/A

Develop Information

Active Companies艾美创新者生物医药研究（上海）有限公司 Aim Vaccine Co Ltd

Inactive CompaniesN/A

Active IndicationsRespiratory Syncytial Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A